The Latest Breaking News from Disease

British health officials will start offering vaccines to gay and bisexual men at the highest risk of catching monkeypox, in an effort to curb the biggest outbreak of the disease beyond Africa

Regulus Therapeutics Inc. (NASDAQ: RGLS) received orphan drug designation from the U.S. Food and Drug Administration (FDA) for its lead drug RGLS8429 in the treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

9 Meters Biopharma Inc (NASDAQ: NMTR) completed a pre-specified interim analysis for the Phase 3 study of larazotide for patients with celiac disease who continue to experience gastrointestinal symptoms while adhering to a gluten-free diet. 

The Supreme Court decides in favor of an insurer in a case focused on reimbursement rates for kidney dialysis.

Eating too much salt comes with a greater risk of high blood pressure, heart attacks and strokes, warned the charity.

Merck & Co Inc (NYSE:MRK) presented results from the Phase 1/2 study, evaluating V116 in pneumococcal vaccine-naïve adults 18-49 years of age (Phase 1) and 50 years of age and older (Phase 2).  Data were shared at the International Symposium on Pneumococci and Pneumococcal Diseases. V116 targets serotypes that account for 85% of…

In Sanskrit, yoga means 'to unite' and describes a way to live a healthy life. Yoga was developed as a spiritual practice thousands of years ago. Today, most westerners do yoga for exercise or to reduce stress. On the occasion of World Yoga Day, celebrated every year on June 21st,…

A multinational study including NIMS nephrologist concludes the finding

Here's a roundup of top developments in the biotech space over the last 24 hours:

The first case of monkeypox in a human was reported in 1970 in the Democratic Republic of the Congo. Since then, there have been many monkeypox outbreaks, but they have been self-limiting, with chains of human transmission ending without establishing epidemics. The current outbreak, however, is different. There is more…

“PFAS? What’s PFAS?”